Monday, July 13, 2020

Coronavirus vaccine update: Russia completes world's first human trial


Coronavirus vaccine latest update: In a major breakthrough, Russia has become the first nation to complete human clinical trials of a Covid-19 vaccine on humans. Catch latest updates on Covid vaccine.


In a major breakthrough, Russia has become the first nation to complete clinical trials of a Covid-19 vaccine on humans, and the results prove the medication's effectiveness, according to media reports. The total number of coronavirus cases across the world has crossed the 13-million mark and the death toll has gone past 570,000.

Given the scale this pandemic is assuming at fast pace, pharmaceutical companies and scientists are working overtime under pressure to come up with a vaccine as soon as possible. There currently are over 100 vaccines at various stages of development worldwide, including in India, Britain, China, the US, Russia and Israel. There are at least 21 vaccines currently under key trials, according to the World Health Organization (WHO).

China's Sinovac Biotech, China National Pharmaceutical Group (Sinopharm) and AstraZeneca's experimental Covid-19 vaccine are in late-stage Phase III trials. Moderna, AstraZeneca, BioNTech, Novavax, Sinovac, CanSino Biologics and Inovio Pharmaceuticals are some players among those leading the race at present.

1. Coronavirus vaccine: Russia first nation to finish human trials
The clinical trials for the world’s first coronavirus vaccine on volunteers at Sechenov First Moscow State Medical University has been successfully completed, Vadim Tarasov, the director of the Institute for Translational Medicine and Biotechnology, told Sputnik, adding that the first group of volunteers would be discharged on Wednesday and the second on July 20.

The university began clinical trials of the vaccine produced by Russia’s Gamalei Institute of Epidemiology and Microbiology on June 18.

Sechenov University has successfully completed tests on volunteers of the world’s first vaccine against coronavirus,” Tarasov said.

No comments:

Post a Comment